Found: 39
Select item for more details and to access through your institution.
Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
- Published in:
- 2018
- By:
- Publication type:
- journal article
EZR-ROS1 fusion renal cell carcinoma mimicking urothelial carcinoma: report of a previously undescribed gene fusion in renal cell carcinoma.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2022, v. 480, n. 2, p. 487, doi. 10.1007/s00428-021-03138-x
- By:
- Publication type:
- Article
Effect Modification by Social Determinants of Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions within an Integrated U.S. Healthcare System.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 7, p. 1145, doi. 10.3390/jpm12071145
- By:
- Publication type:
- Article
The Contribution of Pharmacogenetic Drug Interactions to 90-Day Hospital Readmissions: Preliminary Results from a Real-World Healthcare System.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 12, p. 1242, doi. 10.3390/jpm11121242
- By:
- Publication type:
- Article
EFFICACY AND TOXICITY OF SUNITINIB IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA WITH SEVERE RENAL IMPAIRMENT OR ON HAEMODIALYSIS.
- Published in:
- BJU International, 2011, v. 108, n. 8, p. 1284, doi. 10.1111/j.1464-410X.2011.10179.x
- By:
- Publication type:
- Article
Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33980-9
- By:
- Publication type:
- Article
Bladder-Preserving Trimodality Therapy With Capecitabine.
- Published in:
- Clinical Genitourinary Cancer, 2024, v. 22, n. 2, p. 476, doi. 10.1016/j.clgc.2024.01.002
- By:
- Publication type:
- Article
The role of chemotherapy in upper tract urothelial carcinoma.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 3, p. 623, doi. 10.1007/s10549-020-05603-8
- By:
- Publication type:
- Article
Creation of a pharmacogenomics patient portal complementary to an existing institutional provider-facing clinical decision support system.
- Published in:
- JAMIA Open, 2021, v. 4, n. 3, p. 1, doi. 10.1093/jamiaopen/ooab067
- By:
- Publication type:
- Article
Adoption of a clinical pharmacogenomics implementation program during outpatient care-initial results of the University of Chicago '1,200 Patients Project'.
- Published in:
- American Journal of Medical Genetics. Part C: Seminars in Medical Genetics, 2014, v. 166C, n. 1, p. 68, doi. 10.1002/ajmg.c.31385
- By:
- Publication type:
- Article
Evolving Considerations in the Treatment of Metastatic Bladder Cancer: A Closer Look at the Role of Immunotherapy.
- Published in:
- Journal of Managed Care Medicine, 2020, v. 23, n. 1, p. 68
- By:
- Publication type:
- Article
Patient-Focused Treatment Decisions in Metastatic Bladder Cancer: A Closer Look at the Integration of Immunotherapy.
- Published in:
- Journal of Managed Care Medicine, 2019, v. 22, n. 2, p. 21
- By:
- Publication type:
- Article
Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920974118
- By:
- Publication type:
- Article
Underrepresented patient views and perceptions of personalized medication treatment through pharmacogenomics.
- Published in:
- NPJ Genomic Medicine, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41525-021-00253-1
- By:
- Publication type:
- Article
Incorporating Preemptive Pharmacogenomic Testing Into the Clinical Setting.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, n. 9, p. 526
- By:
- Publication type:
- Article
Validation of a Large Custom-Designed Pharmacogenomics Panel on an Array Genotyping Platform.
- Published in:
- Journal of Applied Laboratory Medicine, 2021, v. 6, n. 6, p. 1505, doi. 10.1093/jalm/jfab056
- By:
- Publication type:
- Article
Validation of an Extensive CYP2D6 Assay Panel Based on Invader and TaqMan Copy Number Assays.
- Published in:
- Journal of Applied Laboratory Medicine, 2017, p. 471, doi. 10.1373/jalm.2016.021923
- By:
- Publication type:
- Article
Pharmacogenomic‐Based Decision Support to Predict Adherence to Medications.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 2, p. 368, doi. 10.1002/cpt.1838
- By:
- Publication type:
- Article
The ImPreSS Trial: Implementation of Point‐of‐Care Pharmacogenomic Decision Support in Perioperative Care.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 6, p. 1179, doi. 10.1002/cpt.1567
- By:
- Publication type:
- Article
Breaking Down Barriers to Effective Patient Care.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 3, p. 360, doi. 10.1002/cpt.1026
- By:
- Publication type:
- Article
Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium Study.
- Published in:
- Prostate, 2016, v. 76, n. 3, p. 286, doi. 10.1002/pros.23119
- By:
- Publication type:
- Article
Spectrum of genomic alterations in FGFR3: current appraisal of the potential role of FGFR3 in advanced urothelial carcinoma.
- Published in:
- BJU International, 2016, v. 118, n. 5, p. 681, doi. 10.1111/bju.13552
- By:
- Publication type:
- Article
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.
- Published in:
- BJU International, 2014, v. 113, n. 5b, p. E137, doi. 10.1111/bju.12564
- By:
- Publication type:
- Article
Assessment of Patient Knowledge and Perceptions of Pharmacogenomics Before and After Using a Mock Results Patient Web Portal.
- Published in:
- CTS: Clinical & Translational Science, 2020, v. 13, n. 1, p. 78, doi. 10.1111/cts.12681
- By:
- Publication type:
- Article
The ACCOuNT Consortium: A Model for the Discovery, Translation, and Implementation of Precision Medicine in African Americans.
- Published in:
- CTS: Clinical & Translational Science, 2019, v. 12, n. 3, p. 209, doi. 10.1111/cts.12608
- By:
- Publication type:
- Article
Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: A report from the Bladder Cancer Advocacy Network Clinical Trials Working Group
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 11, p. 1994, doi. 10.1002/cncr.27973
- By:
- Publication type:
- Article
Identification of novel germline polymorphisms governing capecitabine sensitivity.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 16, p. 4063, doi. 10.1002/cncr.26737
- By:
- Publication type:
- Article
Implementing Preemptive Pharmacogenomics in CLINICAL PRACTICE.
- Published in:
- Clinical Laboratory News, 2018, v. 44, n. 3, p. 18
- By:
- Publication type:
- Article
In Reply.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
In Reply.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Management of Dermatologic Events Associated With the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. e223, doi. 10.1093/oncolo/oyac001
- By:
- Publication type:
- Article
Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid‐Treated Oncology Patients.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. e2042, doi. 10.1002/onco.13953
- By:
- Publication type:
- Article
Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 8, p. 1649, doi. 10.1002/cncr.34104
- By:
- Publication type:
- Article
A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Modern developments in germline pharmacogenomics for oncology prescribing.
- Published in:
- CA: A Cancer Journal for Clinicians, 2022, v. 72, n. 4, p. 315, doi. 10.3322/caac.21722
- By:
- Publication type:
- Article
Germline pharmacogenomics in oncology: Decoding the patient for targeting therapy
- Published in:
- Molecular Oncology, 2012, v. 6, n. 2, p. 251, doi. 10.1016/j.molonc.2012.01.005
- By:
- Publication type:
- Article